sabutoclax (BI 97C1)

Alias: BI-97C1; BI 97C1; BI97C1; Sabutoclax
Cat No.:V0008 Purity: ≥98%
Sabutoclax (BI-97C1),a derivative of apogossypolone, is a novel and potent pan-Bcl-2 inhibitor with IC50 of 0.31 μM, 0.32 μM, 0.20 μM and 0.62 μM forBcl-xL, Bcl-2, Mcl-1 and Bfl-1, respectively.
sabutoclax (BI 97C1) Chemical Structure CAS No.: 1228108-65-3
Product category: Bcl-2
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
10mg
25mg
50mg
100mg
250mg
500mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Sabutoclax (BI-97C1), a apogossypolone derivative, is a novel and potent pan-Bcl-2 inhibitor with IC50 values of 0.31 μM, 0.32 μM, 0.20 μM and 0.62 μM for Bcl-xL, Bcl-2, Mcl-1, and Bfl-1, respectively. It demonstrated strong binding affinity to Bcl-xL in both the NMR binding assay and the ITC assay, with a Kd value of 0.11μM. In comparison to other apogossypolone derivatives, sabutoclax also demonstrated improved cell membrane permeability. Sabutoclax had an EC50 value of 0.13 μM for inhibiting cell growth in PC3 cells. Sabutoclax had an IC50 value of 0.049 μM for inducing cell apoptosis in the human BP3 cell line. Sabutoclax treatment significantly decreased the tumor size in mice receiving cancer xenografts from M2182. Sabutoclax almost completely suppressed tumor growth when administered at a dose of 5 mg/kg.

Biological Activity I Assay Protocols (From Reference)
Targets
Bcl-xL (Ki = 0.31 μ); BCL2 (IC50 = 0.32 μM); Mcl-1 (IC50 = 0.2 μM); Bfl-1 (IC50 = 0.62 μM)
ln Vitro
BI-97C1 potently inhibits cell growth of human prostate cancer, lung cancer, and lymphoma cell lines with EC50 values of 0.13, 0.56, and 0.049 μM, respectively, and shows little cytotoxicity against bax-/-bak-/- cells[1]. It is hypothesized that treatment with the combination of mda-7/IL-24 and BI-97C1 induces autophagy that facilitates apoptosis in conjunction with up-regulation of NOXA, accumulation of Bim, and activation of Bax and Bak[2].
ln Vivo
In addition to showing superior single-agent antitumor efficacy in a prostate cancer mouse xenograft model that relies on Mcl-1 for survival, BI-97C1 also exhibits in vivo efficacy in transgenic mice in which Bcl-2 is overexpressed in splenic B-cells[1]. Ad.5/3-mda-7 and BI-97C1 treatment significantly slows the growth of human PC xenografts in nude mice and spontaneously induced PC in Hi-myc transgenic mice. In both PC xenografts and the prostates of Hi-myc mice, tumor growth inhibition correlates with increased TUNEL staining and decreased Ki-67 expression[2].
Enzyme Assay
A Bak BH3 peptide (F-BakBH3) with the amino acid sequence GQVGRQLAIIGDDINR is purified using HPLC after being FITC-labeled at the N-terminus. For competitive binding assays, 47.5 μL of PBS (pH 7.4) and 100 nM GST-Bcl-XL ΔTM protein are preincubated at room temperature for 10 minutes with the tested substance at varying concentrations. Then, 2.5 μL of 100 nM FITC-labeled Bak BH3 peptide is added to make a final volume of 50 μL. Each assay plate contains both the wild-type and mutant Bak BH3 peptides as positive and negative controls, respectively. At excitation/emission wavelengths of 480/535 nm, following a 30-minute incubation period at room temperature, the polarization values in millipolarization units are determined using a multilabel plate reader. The experimental data are fitted to a sigmoidal dose-response nonlinear regression model to calculate the IC50. The results are the mean of three separate experiments. Bcl-2 and Mcl-1FPA function similarly. In a nutshell, 15 nM of FITC-conjugated-Bim BH3 peptide is added to 50 nM of GST-Bcl-2 or -Mcl-1 in PBS buffer after 2 minutes of incubation with various compound concentrations (4 and 11–14). After 10 minutes, the polarization of the fluorescence is measured.
Animal Protocol
1 , 3, 5 mg/kg
Ethanol:Cremophor EL:saline = 10:10:80
Bcl-2 transgenic mice, human prostate cancer xenografts
References
[1]. J Med Chem . 2010 May 27;53(10):4166-76.

[2]. Proc Natl Acad Sci U S A . 2011 May 24;108(21):8785-90.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C42H40N2O8
Molecular Weight
700.78
Exact Mass
700.28
Elemental Analysis
C, 71.98; H, 5.75; N, 4.00; O, 18.26
CAS #
1228108-65-3
Appearance
Solid powder
SMILES
CC1=CC2=C(C(=C(C=C2C(=C1C3=C(C4=CC(=C(C(=C4C=C3C)C(=O)NC[C@H](C)C5=CC=CC=C5)O)O)O)O)O)O)C(=O)NC[C@H](C)C6=CC=CC=C6
InChi Key
RAYNZUHYMMLQQA-ZEQRLZLVSA-N
InChi Code
InChI=1S/C42H40N2O8/c1-21-15-27-29(17-31(45)39(49)35(27)41(51)43-19-23(3)25-11-7-5-8-12-25)37(47)33(21)34-22(2)16-28-30(38(34)48)18-32(46)40(50)36(28)42(52)44-20-24(4)26-13-9-6-10-14-26/h5-18,23-24,45-50H,19-20H2,1-4H3,(H,43,51)(H,44,52)/t23-,24-/m0/s1
Chemical Name
2,3,5-trihydroxy-7-methyl-N-[(2R)-2-phenylpropyl]-6-[1,6,7-trihydroxy-3-methyl-5-[[(2R)-2-phenylpropyl]carbamoyl]naphthalen-2-yl]naphthalene-1-carboxamide
Synonyms
BI-97C1; BI 97C1; BI97C1; Sabutoclax
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~100 mg/mL (~142.7 mM)
Water: <1 mg/mL(slightly soluble or insoluble)
Ethanol: ~54mg/mL (~77 mM)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.4270 mL 7.1349 mL 14.2698 mL
5 mM 0.2854 mL 1.4270 mL 2.8540 mL
10 mM 0.1427 mL 0.7135 mL 1.4270 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • sabutoclax
    The combination regimen of Sabutoclax and Celecoxib inhibits OSCC tumor growth in athymic nude mice. Oncotarget 6(18):16623-37, 2015
  • sabutoclax

    Genetic or pharmacological knockdown of Mcl-1 sensitizes PC to mda-7/IL-24–mediated apoptosis. PNAS, 108 (21), 8785–8790, 2011
Contact Us